Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-474
HER2amp
Luminal
Taxol
TUBB
TUBB
9158.002
uM
0.00864
0.01271
-0.8158 -0.7150 2.3051 1.0217
0.9943
0.4298
BT-474
HER2amp
Luminal
Taxol
TUBB
TUBB
9163.002
uM
0.00813
0.01227
-0.7896 -0.7362 2.1969 1.0501
0.9969
0.6004
BT-474
HER2amp
Luminal
TCS 2312
CHK1
CHK
12291.152
uM
0.33462
0.95937
-0.5600 -0.7174 0.8448 0.5273
0.9614
0.6792
BT-474
HER2amp
Luminal
TCS 2312
CHK1
CHK
12056.159
uM
0.55373
1.08780
-0.5378 -0.5858 1.1485 0.4584
0.9896
0.9145
BT-474
HER2amp
Luminal
TCS 2312
CHK1
CHK
12178.159
uM
1.25010
1.70650
-0.4681 -0.4697 2.1283 0.3306
0.9939
0.6130
BT-474
HER2amp
Luminal
TCS PIM-1 1
Pim kinase
PIM
12291.135
uM
inf
inf
0.5594 0.5594 0.0000 0.2732
-0.0096
0.4536
BT-474
HER2amp
Luminal
TCS PIM-1 1
Pim kinase
PIM
12178.135
uM
inf
inf
0.9217 0.9217 0.0000 -0.0119
0.2808
0.5524
BT-474
HER2amp
Luminal
TCS PIM-1 1
Pim kinase
PIM
12056.135
uM
inf
inf
0.7081 0.7081 0.0000 0.1158
0.4107
0.9361
BT-474
HER2amp
Luminal
Temsirolimus
MTOR
MTOR
12056.144
uM
0.04627
3.88920
-0.9770 -1.0000 0.2479 0.6966
0.7390
0.9738
BT-474
HER2amp
Luminal
Temsirolimus
MTOR
MTOR
12178.144
uM
0.00674
4.77920
-0.5971 -1.0000 0.1674 0.7546
0.7765
0.7891
BT-474
HER2amp
Luminal
Temsirolimus
MTOR
MTOR
12291.168
uM
-inf
0.00735
-0.9999 -1.0000 0.2001 1.2788
0.8809
0.4466
BT-474
HER2amp
Luminal
Topotecan
TOP1
TOP
9163.121
uM
0.71948
2.42440
-0.7636 -0.8550 0.8207 0.5390
0.9879
0.4382
BT-474
HER2amp
Luminal
Topotecan
TOP1
TOP
7798.077
uM
31.4570
8.71650
0.3936 0.3174 0.7847 0.1331
0.9887
1.4371
BT-474
HER2amp
Luminal
Topotecan
TOP1
TOP
9158.121
uM
2.47970
4.70910
-0.5275 -0.5447 1.1489 0.3894
0.9893
1.0691
BT-474
HER2amp
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12178.16
uM
inf
inf
0.2658 0.2658 0.0000 0.1429
0.5449
0.7392
BT-474
HER2amp
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12056.16
uM
21.99290
50.19930
0.2578 -1.0000 1.3312 0.1084
0.7948
0.9124
BT-474
HER2amp
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12291.169
uM
6.18190
14.50510
-0.9859 -1.0000 1.2881 0.3744
0.9158
0.3548
BT-474
HER2amp
Luminal
TPCA-1
IKK
NFKB
5905.093
uM
inf
inf
0.8892 0.8892 0.0000 -0.0060
0.0525
0.9101
BT-474
HER2amp
Luminal
Trametinib
MEK
MAPK
9157.012
uM
inf
inf
0.7933 0.7933 0.0000 0.0840
0.4934
0.8641
BT-474
HER2amp
Luminal
Trametinib
MEK
MAPK
9163.024
uM
44.54640
122.93040
0.7877 -0.9791 1.0684 0.0080
0.7001
0.5524
BT-474
HER2amp
Luminal
Trastuzumab
HER2
ErbB
9158.123
uM
0.01277
0.00885
-0.0100 0.0993 0.6043 0.4533
0.9046
0.8769
BT-474
HER2amp
Luminal
Trastuzumab
HER2
ErbB
9163.026
uM
0.00135
0.0020
-0.6688 -0.4240 1.5559 0.8993
0.9648
0.3738
BT-474
HER2amp
Luminal
Trichostatin A
HDAC
HDAC
5906.065
uM
7.71060
10.80850
-0.9938 -0.9980 3.2489 0.9661
0.9945
0.6586
BT-474
HER2amp
Luminal
Trichostatin A
HDAC
HDAC
5905.065
uM
10.69090
15.04820
-0.9632 -0.9609 3.1364 0.8807
0.9976
0.8461
BT-474
HER2amp
Luminal
Triciribine
AKT
AKT
5906.074
uM
0.01550
0.02634
-0.2986 -0.2004 0.6357 0.6325
0.9018
0.6442